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Abstract—With more patients taking multiple medications
and the increasing digital availability of diagnostic data such
as treatment notes and x-ray images, the importance of decision
support systems to help dentists in their treatment planning
cannot be over emphasised. Based on the hypothesis that a
higher similarity ratio between drugs in a drug-pair indicates
that the combination of the drug-pair has a higher chance of an
adverse interaction, this paper describes an efficient approach
in extracting feature vectors from the drugs in a drug-pair to
compute the similarity ratio between them. The feature vectors
are obtained through a network model where the information
of the drugs are represented as nodes and the relationships
between them represented as edges. Experimental evaluation
of our model yielded a superior F score of 74%.
The use of a network model will drive research efforts into
more efficient data-mining algorithms for information retrieval,
similarity search and machine learning. Since it is important
to avoid drug allergies when prescribing drugs, our work when
integrated within the clinical work-flow will reduce prescription
errors thereby increasing health outcomes for patients.
Keywords-drug adverse interaction; clinical decision support;
network model; drug prescription;
I. INTRODUCTION
The amount of data available to dentists has increased
tremendously in recent years. This has led to increasing
dependence on a clinical decision support system (CDSS)
to aid the treatment planning process especially for drug
prescription. Drugs such as painkillers and antibiotics
are very commonly prescribed in the dental setting
to relieve pain and resolve infections, in primary and
supplementary roles. Reducing and relieving pain with
analgesic medications are naturally important procedures
within the clinical work-flow of a dental clinic [7]. For
patients with an abscessed tooth, common drugs such as
amoxicillin and clindamycin are also used to treat the
infections as a supplement to a root canal treatment or
removing the tooth. Antibiotics are also used after surgical
procedures such as placement of dental implants and gum
treatment [10].
Though there are systems which examine the interactions
within a pair of drugs, they are not associated with the
medical profile of the patient. Hence, we aim to pursue a
framework which obtains content-specific data from publicly
available data sources, performs data-mining on the data
and presents the results to the dentist with consideration
of the individual patient’s drug allergies and the drugs
they are currently taking. Although the data-mining layer
of our three-tier framework can include many approaches
for extracting information, this paper examines the use
of a network model which is based on the hypothesis
that a higher similarity ratio indicates a greater chance of
an adverse interaction between drugs in a drug-pair. The
network model provides an effective platform for obtaining
feature vectors and hence their similarity ratio based on the
number of common paths connecting the set of common
interacting drugs between the drug-pair. In our model, we
represent all drugs as nodes in a network to enable us to
compute their proximity in terms of the number of shared
entities between the drug-pair as reflected in the number
of connecting paths between them. The primary theoretical
contribution of this research is the use of the network
model in hierarchically representing the drug-pairs within
the context of a CDSS considering the individual patient’s
medical profile. Examining the paths linking the common
drugs within the set of interacting drugs for each drug in the
drug-pair allows the system to arrive at a similarity ratio.
This then allows the dentist to decide if the drug is safe
for the patient. Such a system containing information on
interacting drug-pairs based on the patient’s personal profile
will also be useful in clinical education relating to drug
dispensing, such as in medicine, nursing and pharmacy.
The rest of paper is organised as follows: Section II
discusses the related work in data-mining and detection of
interactive drug-pairs; Section III explains the framework
and Section IV describes the experiment while the results
are discussed in V. Section VI describes a clinical scenario
to demonstrate if a drug is safe based on a specific patient’s
profile and Section VII presents the conclusions obtained
with an outline of potential future work.
II. RELATED WORK
Many works on drug interactions have been performed in
recent years, notwithstanding the lack of a single dataset
with information on drug interactions from all publicly
available sources [1]. Hence, knowledge representation as
per the source of the dataset is used in the design of many
CDSS for making diagnostic inferences ( [6], [5])
By using data-mining techniques, semantic meanings and
context-specific knowledge based on medical profiles of
patients can be obtained from the knowledge base. Wright
et al. used a data-mining method to identify relationships
between diabetic medications [12]. By identifying patterns
within the drug database, the system was able to predict
the subsequent medication to be prescribed with significant
accuracy.
When predicting the relationship of a drug-pair, relevant
information from knowledge bases are usually extracted and
examined. For example, Tari et al. developed a method
combining text mining and automated reasoning to predict
enzyme-specific drug-drug interactions (DDI) [11]. Yan et
al. also used text mining techniques to create features based
on relevant information such as genes and disease names
extracted from drug databases to augment limited domain
knowledge [13]. These features were then used to build a
logistic regression model to predict DDI.
Though these systems predict the extent of drug
interaction within the drug-pair, they are not customised to
the medical profile of the patient. Of the many methods
used to create feature vectors to compute the similarity of a
drug-pair to predict DDI, this paper will explore the use of
a network model, where drugs are represented on each node
with their relationship represented as edges. This model fits
into the data-mining layer of our framework as elaborated
in the next section.
III. FRAMEWORK
As mentioned earlier, knowledge representation is
a typical technique used in CDSS development. The
knowledge base needs to be updated regularly to represent
knowledge in a timely manner, which is imperative for
CDSS user acceptance [3]. The separation of the knowledge
base from the main information systems allows the former
to be updated and managed effectively, for each layer
to be developed and maintained independently while
simultaneously ensuring standardised interfacing between
layers and cheaper integration with existing systems [4].
Figure 1: Three-tier architecture of the proposed model
Hence our framework has a three-tier architecture (Figure
1) which separates the knowledge layer containing the
knowledge base from the data-mining layer and the
presentation layer.
The network model, residing in the data-mining layer
aims to compute the similarity ratio of a drug-pair based
on the feature vectors gathered from the knowledge layer.
Our approach adapts from [2] which describes the theoretical
foundations of measuring similarity within a network.
To obtain the feature vectors and the similarity ratio within
this model, the logarithm begins by formally defining the
set of interactive drugs as Ar = {a1, a2...ak} where r is the
attribute of the relationship with the vertex drug-pair, which
can be minor, moderate or major.
The items in A is also the subset of out-neighbours of drug
d1, denoted as O(d1). Individual drugs in A which interact
with d1 is then denoted by Oi(d1)(1 ≤ i ≤ |O(d1)|). Hence,
Oi(d1) ∈ {Ar}
This is followed by getting the path and the vectors
Get Path Using notation from [9], the path from drug
d1 to set of interactive drugs A with ratings r is denoted
by: d1
r−→ A, which can also be written as d1(r)A where
r is the relationship between d1 and A. For our model, the
relationship r = {1, 2, 3}.
Thus, d1(1)A shows drug d1 has a minor interaction with
the drugs in set A.
Get Vectors Create single row matrix Mr for drugs d1
and d2 to indicate the positional match in the adverse drugs
for d1 and d2 with interaction rating r where the number of
columns in Mr = |Ar|.
If Oi(d1) is found in Ar at position u, then the uth column
in matrix Mr will be updated as r, Mr(1, u)←− r.
IV. EXPERIMENT
We chose an experimental approach to assess the accuracy
and efficiency of the proposed method, testing the hypothesis
that similar drug-pairs have a higher similarity ratio
compared to that of dissimilar pairs.
The comprehensive dataset on DDI required for this
project was sourced from drugbank.ca, a richly annotated
database popularly used to build drug repositories on drug
indications [8].
From the set of drugs that interacts adversely with each
drug in the drug-pair, paths and feature vectors were built.
This data-mining process aimed to discover the number of
common paths for each drug-pair. As explained in Section
III, vectors were then built so that a similarity ratio can be
computed for the drug-pair.
With the similarity ratio results from the experiment, a
threshold of θ = 0.5 was used to predict if the drug-pair
was similar. A value of 0.5 or higher meant the drug-pair
was considered similar, and a value lower than 0.5 meant
the drug-pair was considered dissimilar. The performance
of the model was measured by counting the number of
correct predictions (true positives). For convenience and ease
of computation, the standard metrics recall, precision and
F score were used to gauge how well the prediction was
being made. Precision indicated how accurately the model
predicted drug-pairs as similar, while recall indicated how
accurately similar drug-pairs were predicted. Thus,
precision =
TP
TP + FP
recall =
TP
TP + FN
(1)
where TP is True Positive, FN is False Negative, and FP
False Positive.
V. RESULTS AND DISCUSSION
Cut off r=1 r=1 r=2 r=2
(Major) (Combined) (Major) (Combined)
0.1 0.55 0.61 0.52 0.70
0.2 0.51 0.55 0.45 0.59
0.3 0.57 0.42 0.41 0.49
0.4 0.68 0.44 0.40 0.44
0.5 0.74 0.43 0.47 0.36
0.6 0.74 0.43 - 0.35
0.7 0.71 0.41 - 0.38
0.8 0.68 0.39 - 0.34
0.9 0.67 0.39 - -
Table I: F score distribution
Table I shows the F score when the experiment is run
with a dataset of positive pairs and negative pairs. When
the threshold is 0.5, the model produces a F score of 0.74
with a recall rate of 0.61 and precision of 0.94. r=1 indicates
only common paths in the direct neighbourhood of the drug
is considered. When the distance is extended at r=2, where
paths connecting the drugs that interact with the drug-pair
are also considered, it can be noticed that the F score drops
drastically. As expected, the performance deteriorated when
additional attributes of adverse interactions were introduced
such as minor and moderate interactions. However, due to
fewer possible paths when only major interactions were
considered, the cut-off occurs sooner, where beyond that,
there were no true positives obtained in the experiment. This
explains the unavailability of F score when the threshold was
over 0.6.
Since both positive and negative outcomes are important
within the clinical workflow, we also examined the
performance of our model to predict true negatives. To do so,
a plot of true positive rate tpr against true negative rate tnr
(Equation 2) was used to obtain the area under the receiver
operating characteristic curve (AUC).
tpr =
TP
TP + FN
tnr =
FP
FP + TN
(2)
With this plot, at r=1 with paths connecting only the major
interactions considered, the AUC yielded 0.61 compared to
0.36 when minor and moderate interactions were included.
This was expected due to the noise introduced by the
additional paths.
VI. ADAPTING THE MODEL TO PRESCRIPTION SUPPORT
FOR DENTAL CLINICS
Our three-tier framework can be easily applied to a
clinical environment to support the prescription of drugs
to patients. This section describes a typical CDSS to help
decide if the drug is safe for prescription.
Given the set of prescription drugs, an algorithm can be
developed to adapt the framework to a clinical scenario to
ensure the drug is not in adverse relationship with what the
patient is taking and is dissimilar to the drugs that the patient
is allergic to.
From Algorithm 1, there are two tests that consider the
adverse relationship and the similarity within drug-pairs. To
facilitate suggestion of an alternative drug by the system, a
set of candidate drugs, similar to the drug to be prescribed,
was created. Based on the relationship within drug-pairs
in the drug taxonomy located in the knowledge layer,
the system searched for any adverse relationship between
the drug to be prescribed and each drug that the patient
is currently taking. If there was no adverse relationship
detected, the system proceeded to test for similarity between
the drug to be prescribed and each drug in the set of drugs
that the patient is allergic to. Each drug in the prescription set
of drugs had to clear both tests. If either test was not cleared,
an alternative drug in the candidate set was suggested. If
the candidate set was exhausted, the system would then be
unable to recommend an alternative drug.
Consider a patient who is allergic to penicillin and is
currently taking warfarin. During a dental appointment, it
is decided that antibiotics are required. The dentist may
consider the commonly prescribed amoxicillin. Use of our
model will note the similarity of amoxicillin to penicillin,
which the patient is allergic to, and will thus recommend
an alternative drug. As indicated in Algorithm 1, not only
should this drug be dissimilar to penicillin, it should also
not be in adverse relationship with warfarin. One such drug
Algorithm 1: Applying Model for personalised
prescription support
input : Let Dp be the set of prescription drugs;
Medicine to be prescribed by the dentist
Medicine the patient is currently taking
Medicine the patient is allergic to
output: recommended prescription
1 Let δ be the flag for adverse relationship of drug-pair
2 Let θ be the threshold of similarity of drug class of
drug-pair
3 Initialise δ to false and θ to false
4 while there are more medicine in Dp do
5 get drug ID drugID in prescription set
6 create default candidate set that belongs to same
class as drugID
7 set recommended medicine dr be medicine from
prescription set
8 while δ is false or θ is false do
9 while there are more medicine that patient is
taking do
10 if adverse relationship exists between dr
and medicine that patient is taking then
11 δ = false;
12 break from loop;
13 end
14 end
15 while there are more medicine the patient is
allergic to do
16 if dr belongs to same class as medicine
that patient is allergic to then
17 θ = false;
18 break from loop
19 end
20 end
21 if (δ == false ) or (θ == false) then
22 get dr from next item in candidate set
23 end
24 if there are no more items in candidate set
then
25 break and exit from testing for δ,θ
26 end
27 end
28 display recommended medicine
29 end
that fits both criteria is troleandomycin. On receiving the
suggestion of this alternative drug, the dentist can then
decide whether it is appropriate to be prescribed after further
consideration of the duration and dosage of the patient’s
current medications.
VII. CONCLUSION
This paper presents the use of a network model in
the data-mining of bio-medical data within a three-tier
framework, allowing easy updating of the knowledge base
and effective presentation of results to the user. Experimental
results show that this model performs better when only
nodes within the direct neighbourhood of the drug-pair are
used to find the common paths within the network. Besides
the network model, we plan to compare and contrast this
approach with the word embedding approach, where feature
vectors are based on the nearest terms to the drug-pair. Not
only will this study aid implementation of a personalised
CDSS to benefit dentists in the prescription of drugs at
point-of-care, our work will also provide potential for more
efficient algorithms with the use of a network model in
information retrieval, similarity search and machine learning.
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